Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2003.018531v1
63/8/901    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, W
Right arrow Articles by Doherty, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, W
Right arrow Articles by Doherty, M
Annals of the Rheumatic Diseases 2004;63:901-907
© 2004 by BMJ Publishing Group Ltd & European League Against Rheumatism


REVIEW

Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled trials

W Zhang 1, A Jones 2, M Doherty 1

1 Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK
2 Rheumatology Unit, Nottingham City Hospital, Nottingham NG5 1PB, UK

Correspondence to:
Correspondence to:
Dr W Zhang
Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK; weiya.zhang{at}nottingham.ac.uk


ABSTRACT
Objective: To assess the best available evidence for efficacy of paracetamol (acetaminophen) in the treatment of osteoarthritis (OA).

Design: Systematic review and meta-analysis of randomised controlled trials (RCTs).

Data sources: Medline, Embase, Scientific Citation Index, CINAHL, Cochrane Library, and conference abstracts in the past 2 years from the British Society for Rheumatology, the European League Against Rheumatism, the American College of Rheumatology, and the Osteoarthritis Research Society International.

Subjects: 10 RCTs including 1712 patients with either symptomatic OA of the knee (6 trials) or hip/knee (3 trials) or multiple joints (1 trial).

Main outcome measures: (a) effect size (ES) for pain, stiffness, and functional scores from baseline to end point; (b) rate ratio (RR) and number needed to treat for clinical response rate and patient preference for treatment.

Results: Paracetamol was effective in relieving pain due to OA (ES = 0.21, 95% confidence interval (CI) 0.02 to 0.41). Non-steroidal anti-inflammatory drugs (NSAIDs) were better than paracetamol for pain relief (ES = 0.20, 95% CI 0.10 to 0.30). Clinical response rate was higher with NSAIDs than with paracetamol (RR = 1.24, 95% CI 1.08 to 1.41), and the number of patients who preferred NSAIDs was more than twice the number of those preferring paracetamol (RR = 2.46, 95% CI 1.51 to 4.12). NSAIDs were associated with more frequent gastrointestinal discomfort than paracetamol (RR = 1.35, 95% CI 1.05 to 1.75).

Conclusion: Paracetamol is an effective agent for pain relief due to OA. Although safer, it is less effective than NSAIDs. For safety reasons paracetamol should be the first line treatment, with NSAIDs reserved for those who do not respond.


Abbreviations: ACR, American College of Rheumatology; CI, confidence interval; ES, effect size; EULAR, European League Against Rheumatism; GI, gastrointestinal; MeSH, medical subject heading; NNT, number needed to treat; NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis; RCT, randomised controlled trial; RR, rate ratio; WOMAC, Western Ontario and McMaster Universities OA Index

Keywords: paracetamol; osteoarthritis; meta-analysis; randomised controlled trials




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
R. Chou, A. Qaseem, V. Snow, D. Casey, J. T. Cross Jr, P. Shekelle, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
Ann Intern Med, October 2, 2007; 147(7): 478 - 491.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. Chou and L. H. Huffman
Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline
Ann Intern Med, October 2, 2007; 147(7): 505 - 514.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
C.K.S. Ong, P. Lirk, C.H. Tan, and R.A. Seymour
An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs
Clin. Med. Res., March 1, 2007; 5(1): 19 - 34.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
W Zhang, M Doherty, B F Leeb, L Alekseeva, N K Arden, J W Bijlsma, F Dincer, K Dziedzic, H J Hauselmann, G Herrero-Beaumont, et al.
EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Ann Rheum Dis, March 1, 2007; 66(3): 377 - 388.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
J Bjordal and P G Conaghan
NSAIDs in osteoarthritis: irreplaceable or troublesome guidelines?
Br. J. Sports Med., April 1, 2006; 40(4): 285 - 286.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
J Zochling, D van der Heijde, R Burgos-Vargas, E Collantes, J C Davis Jr, B Dijkmans, M Dougados, P Geher, R D Inman, M A Khan, et al.
ASAS/EULAR recommendations for the management of ankylosing spondylitis
Ann Rheum Dis, April 1, 2006; 65(4): 442 - 452.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
W Zhang, M Doherty, N Arden, B Bannwarth, J Bijlsma, K-P Gunther, H J Hauselmann, G Herrero-Beaumont, K Jordan, P Kaklamanis, et al.
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Ann Rheum Dis, May 1, 2005; 64(5): 669 - 681.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
R. Lehman
Evidently...
Evid. Based Med., February 1, 2005; 10(1): 8 - 8.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., February 1, 2005; 10(1): 31 - 32.
[Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
C. R Kessenich
Review: paracetamol reduces pain in osteoarthritis but is less effective than NSAIDs
Evid. Based Nurs., January 1, 2005; 8(1): 21 - 21.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
L Denoeud, B Mazieres, C Payen-Champenois, and P Ravaud
First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence
Ann Rheum Dis, January 1, 2005; 64(1): 70 - 74.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. MacAuley
Managing osteoarthritis of the knee
BMJ, December 4, 2004; 329(7478): 1300 - 1301.
[Full Text] [PDF]


Home page
BMJHome page
J. M. Bjordal, A. E. Ljunggren, A. Klovning, and L. Slordal
Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials
BMJ, December 4, 2004; 329(7478): 1317.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R Neame, W Zhang, and M Doherty
A historic issue of the Annals: three papers examine paracetamol in osteoarthritis
Ann Rheum Dis, August 1, 2004; 63(8): 897 - 900.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & European League Against Rheumatism